rdf:type |
|
lifeskim:mentions |
|
pubmed:issue |
2
|
pubmed:dateCreated |
2009-2-13
|
pubmed:abstractText |
Entecavir has demonstrated clinical efficacy for chronic hepatitis B. This study evaluated the efficacy and safety of entecavir in nucleoside-naive Japanese chronic hepatitis B patients.
|
pubmed:language |
eng
|
pubmed:journal |
|
pubmed:citationSubset |
IM
|
pubmed:chemical |
|
pubmed:status |
MEDLINE
|
pubmed:month |
Feb
|
pubmed:issn |
1440-1746
|
pubmed:author |
pubmed-author:IkedaHiroshiH,
pubmed-author:ImazekiFumioF,
pubmed-author:KageMasayoshiM,
pubmed-author:KobashiHaruhikoH,
pubmed-author:MoriyamaMitsuhikoM,
pubmed-author:OmataMasaoM,
pubmed-author:SakaguchiKousakuK,
pubmed-author:SeriuTakuT,
pubmed-author:ShiratoriYasushiY,
pubmed-author:TakaguchiKouichiK,
pubmed-author:YokosukaOsamuO
|
pubmed:issnType |
Electronic
|
pubmed:volume |
24
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
255-61
|
pubmed:meshHeading |
pubmed-meshheading:19215336-Adult,
pubmed-meshheading:19215336-Antiviral Agents,
pubmed-meshheading:19215336-Asian Continental Ancestry Group,
pubmed-meshheading:19215336-DNA, Viral,
pubmed-meshheading:19215336-Double-Blind Method,
pubmed-meshheading:19215336-Drug Resistance, Viral,
pubmed-meshheading:19215336-Female,
pubmed-meshheading:19215336-Guanine,
pubmed-meshheading:19215336-Hepatitis B, Chronic,
pubmed-meshheading:19215336-Hepatitis B e Antigens,
pubmed-meshheading:19215336-Hepatitis B virus,
pubmed-meshheading:19215336-Humans,
pubmed-meshheading:19215336-Japan,
pubmed-meshheading:19215336-Liver,
pubmed-meshheading:19215336-Male,
pubmed-meshheading:19215336-Middle Aged,
pubmed-meshheading:19215336-Severity of Illness Index,
pubmed-meshheading:19215336-Time Factors,
pubmed-meshheading:19215336-Treatment Outcome,
pubmed-meshheading:19215336-Viral Load
|
pubmed:year |
2009
|
pubmed:articleTitle |
Efficacy and safety of entecavir in nucleoside-naive, chronic hepatitis B patients: phase II clinical study in Japan.
|
pubmed:affiliation |
Department of Gastroenterology and Hepatology, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, Okayama, Japan. hkobashi@md.okayama-u.ac.jp
|
pubmed:publicationType |
Journal Article,
Randomized Controlled Trial,
Research Support, Non-U.S. Gov't,
Multicenter Study,
Clinical Trial, Phase II
|